These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24390132)

  • 41. Involvement of corneodesmosome degradation and lamellar granule transportation in the desquamation process.
    Ishida-Yamamoto A; Kishibe M
    Med Mol Morphol; 2011 Mar; 44(1):1-6. PubMed ID: 21424930
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of kallikrein-related peptidases in the skin - from physiology to diseases to therapeutic options.
    Fischer J; Meyer-Hoffert U
    Thromb Haemost; 2013 Sep; 110(3):442-9. PubMed ID: 23446429
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of hepatocyte growth factor activator zymogen (pro-HGFA) by human kallikrein 1-related peptidases.
    Mukai S; Fukushima T; Naka D; Tanaka H; Osada Y; Kataoka H
    FEBS J; 2008 Mar; 275(5):1003-17. PubMed ID: 18221492
    [TBL] [Abstract][Full Text] [Related]  

  • 44. LEKTI, a novel 15-domain type of human serine proteinase inhibitor.
    Mägert HJ; Ständker L; Kreutzmann P; Zucht HD; Reinecke M; Sommerhoff CP; Fritz H; Forssmann WG
    J Biol Chem; 1999 Jul; 274(31):21499-502. PubMed ID: 10419450
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human mesotrypsin is a unique digestive protease specialized for the degradation of trypsin inhibitors.
    Szmola R; Kukor Z; Sahin-Tóth M
    J Biol Chem; 2003 Dec; 278(49):48580-9. PubMed ID: 14507909
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7.
    Caubet C; Jonca N; Brattsand M; Guerrin M; Bernard D; Schmidt R; Egelrud T; Simon M; Serre G
    J Invest Dermatol; 2004 May; 122(5):1235-44. PubMed ID: 15140227
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies.
    Avgeris M; Scorilas A
    Expert Opin Ther Targets; 2016 Jul; 20(7):801-18. PubMed ID: 26941073
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome.
    Briot A; Deraison C; Lacroix M; Bonnart C; Robin A; Besson C; Dubus P; Hovnanian A
    J Exp Med; 2009 May; 206(5):1135-47. PubMed ID: 19414552
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The serine protease inhibitor of Kazal-type 9 (SPINK9) is expressed in lichen simplex chronicus, actinic keratosis and squamous cell carcinoma.
    Redelfs L; Fischer J; Weber C; Wu Z; Meyer-Hoffert U
    Arch Dermatol Res; 2016 Mar; 308(2):133-7. PubMed ID: 26746658
    [TBL] [Abstract][Full Text] [Related]  

  • 50. LEKTI: a multidomain serine proteinase inhibitor with pathophysiological relevance.
    Mägert HJ; Kreutzmann P; Ständker L; Walden M; Drögemüller K; Forssmann WG
    Int J Biochem Cell Biol; 2002 Jun; 34(6):573-6. PubMed ID: 11943586
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The solution structure of the kallikrein-related peptidases inhibitor SPINK6.
    Jung S; Fischer J; Spudy B; Kerkow T; Sönnichsen FD; Xue L; Bonvin AM; Goettig P; Magdolen V; Meyer-Hoffert U; Grötzinger J
    Biochem Biophys Res Commun; 2016 Feb; 471(1):103-8. PubMed ID: 26828269
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SPINK9 stimulates metalloprotease/EGFR-dependent keratinocyte migration via purinergic receptor activation.
    Sperrhacke M; Fischer J; Wu Z; Klünder S; Sedlacek R; Schroeder JM; Meyer-Hoffert U; Reiss K
    J Invest Dermatol; 2014 Jun; 134(6):1645-1654. PubMed ID: 24441102
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activation profiles of human kallikrein-related peptidases by proteases of the thrombostasis axis.
    Yoon H; Blaber SI; Evans DM; Trim J; Juliano MA; Scarisbrick IA; Blaber M
    Protein Sci; 2008 Nov; 17(11):1998-2007. PubMed ID: 18697857
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of LEKTI domains 6-9' in the baculovirus expression system: recombinant LEKTI domains 6-9' inhibit trypsin and subtilisin A.
    Jayakumar A; Kang Y; Mitsudo K; Henderson Y; Frederick MJ; Wang M; El-Naggar AK; Marx UC; Briggs K; Clayman GL
    Protein Expr Purif; 2004 May; 35(1):93-101. PubMed ID: 15039071
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human kallikrein-related peptidase 14 (KLK14) is a new activator component of the KLK proteolytic cascade. Possible function in seminal plasma and skin.
    Emami N; Diamandis EP
    J Biol Chem; 2008 Feb; 283(6):3031-3041. PubMed ID: 18056261
    [TBL] [Abstract][Full Text] [Related]  

  • 56. KLK5 and KLK7 Ablation Fully Rescues Lethality of Netherton Syndrome-Like Phenotype.
    Kasparek P; Ileninova Z; Zbodakova O; Kanchev I; Benada O; Chalupsky K; Brattsand M; Beck IM; Sedlacek R
    PLoS Genet; 2017 Jan; 13(1):e1006566. PubMed ID: 28095415
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Homologous proteins with different folds: the three-dimensional structures of domains 1 and 6 of the multiple Kazal-type inhibitor LEKTI.
    Lauber T; Schulz A; Schweimer K; Adermann K; Marx UC
    J Mol Biol; 2003 Apr; 328(1):205-19. PubMed ID: 12684009
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression, purification and characterization of recombinant human serine proteinase inhibitor Kazal-type 6 (SPINK6) in Pichia pastoris.
    Lu H; Huang J; Li G; Ge K; Wu H; Huang Q
    Protein Expr Purif; 2012 Mar; 82(1):144-9. PubMed ID: 22212898
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of serine protease inhibitor Kazal type-5 (SPINK5) gene expression in the keratinocytes.
    Le NA; Katsuyama M; Demura M; Tanii H; Katsuyama H; Saijoh K
    Environ Health Prev Med; 2014 Jul; 19(4):307-13. PubMed ID: 24894987
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aberrant serine protease activities in atopic dermatitis.
    Morizane S; Sunagawa K; Nomura H; Ouchida M
    J Dermatol Sci; 2022 Jul; 107(1):2-7. PubMed ID: 35817663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.